Copyright
©The Author(s) 2025.
World J Gastrointest Surg. May 27, 2025; 17(5): 102064
Published online May 27, 2025. doi: 10.4240/wjgs.v17.i5.102064
Published online May 27, 2025. doi: 10.4240/wjgs.v17.i5.102064
Table 1 Advantages and disadvantages of proactive pharmacologic strategy for Crohn’s disease patient post-ileocecal resection, and proposed qualification criteria
| Qualification criteria | Advantages | Disadvantages |
| History of multiple bowel resections | Lower risk of disease recurrence | Higher cost |
| Perianal involvement | Lower risk of disease-related complications | Risk of overtreatment |
| Penetrating disease behavior | ||
| Patients under 30 years old | ||
| Smokers | ||
| Presence of granulomas in resection specimen | ||
| Presence of myenteric plexitis |
Table 2 Detailed description of REMIND score according to Hammoudi et al[54]
| REMIND score | |
| Anastomotic lesions (< 1 cm in length after the anastomosis) | |
| A(0) | No lesion |
| A(1) | Ulcerations covering less than 50% of the anastomosis circumference |
| A(2) | Ulcerations covering more than 50% of the anastomosis circumference |
| A(3) | Anastomotic stenosis |
| Ileal lesions | |
| I(0) | No lesion |
| I(1) | ≤ 5 aphthous ulcers |
| I(2) | > 5 aphthous lesions with normal intervening mucosa or skip areas of larger lesions |
| I(3) | Diffuse aphthous ileitis with diffusely inflamed mucosa |
| I(4) | Diffuse inflammation with larger ulcers |
- Citation: Cwaliński J, Stawczyk-Eder K, Cwalinska A, Zasada W, Cholerzyńska H, Banasiewicz T, Paszkowski J. Insufficiency of ileocolic anastomosis in Crohn’s disease patients – prevention and treatment. World J Gastrointest Surg 2025; 17(5): 102064
- URL: https://www.wjgnet.com/1948-9366/full/v17/i5/102064.htm
- DOI: https://dx.doi.org/10.4240/wjgs.v17.i5.102064
